# Synergistic effect of early enteral and parenteral nutrition on immune and nutritional recovery following gastric cancer surgery

**Authors:** Jialong Tao, Xiuluan Du, Haixia Xu, Liya Dai, Chen Zhang, Wenwen Gao, Sijia Huang, Yanjie Wang, Jing Sun, Wenlu Zhao

PMC · DOI: 10.3389/fsurg.2025.1679918 · Frontiers in Surgery · 2026-01-06

## TL;DR

Combining early enteral and parenteral nutrition after gastric cancer surgery improves recovery, immunity, and reduces inflammation.

## Contribution

This study demonstrates the synergistic benefits of early enteral and parenteral nutrition in post-surgery gastric cancer patients.

## Key findings

- Combined nutrition reduced hospital stay and improved gastrointestinal recovery.
- Nutritional and immune markers were significantly better in the combined group.
- Inflammatory stress and complications were lower with combined nutrition.

## Abstract

In this study, we aimed to explore the effects of early enteral nutrition (EN) combined with parenteral nutrition (PN) on the immune function and nutritional indices in patients with gastric cancer (GC) after surgery.

A total of 100 patients who underwent radical gastrectomy in our hospital between June 2022 and June 2023 were selected and divided into control (CG) and observation (OG) groups. The patients in the CG received early EN support, whereas those in the OG received early EN combined with supportive PN treatment. Gastrointestinal functional recovery, length of hospital stay, nutritional indices, immune function, inflammatory stress index, and the incidence of complications in both groups were compared.

The time to first flatus, time to first defecation, time to tolerance of semi-liquid diet, and the length of hospital stay were shorter in the OG than that in the CG (P < 0.05). After nutritional support, the albumin, total protein (TP), and transferrin levels in the OG were higher than those in the CG (P < 0.05). In addition, immunoglobulin (Ig)G, IgM, and IgA levels were higher in the OG group than those in the CG group (P < 0.05). Moreover, tumor necrosis factor-α, IL-6, and C-reactive protein levels in the OG were lower compared to those in the CG (P < 0.05). The incidence of complications was lower in the OG than in the CG (P < 0.05).

For patients with GC, the combined application of early EN and PN support measures after surgery can accelerate the recovery of gastrointestinal function, reduce complications, improve the body's nutritional status, promote the recovery of immune function, and lower the inflammatory stress response.

## Linked entities

- **Proteins:** LOC100189571 (uncharacterized LOC100189571), Tsf2 (transferrin 2), IL6 (interleukin 6)
- **Diseases:** gastric cancer (MONDO:0001056)

## Full-text entities

- **Genes:** TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TF (transferrin) [NCBI Gene 7018] {aka HEL-S-71p, PRO1557, PRO2086, TFQTL1}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}
- **Diseases:** inflammatory (MESH:D007249), GC (MESH:D013274)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12816182/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12816182/full.md

## References

29 references — full list in the complete paper: https://tomesphere.com/paper/PMC12816182/full.md

---
Source: https://tomesphere.com/paper/PMC12816182